Abnormal Accumulation of Desmin in Gastrocnemius Myofibers of Patients with Peripheral Artery Disease: Associations with Altered Myofiber Morphology and Density, Mitochondrial Dysfunction and Impaired Limb Function

Journal of Histochemistry and Cytochemistry

Volumn 63, Issue 4, 2015, Pages 256-269

  Koutakis, Panagiotis ^a   Miserlis, Dimitrios ^a   Myers, Sara A ^a   Kim, Julian Kyung Soo ^a   Zhu, Zhen ^a   Papoutsi, Evlampia ^a   Swanson, Stanley A ^a   Haynatzki, Gleb ^b   Ha, Duy M ^a   Carpenter, Lauren A ^a   McComb, Rodney D ^b   Johanning, Jason M ^a,c   Casale, George P ^a   Pipinos, Iraklis I I ^a,c  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Cytoskeleton; desmin; intermittent claudication; muscle disease; myofiber

Indexed keywords

CYTOCHROME C OXIDASE; DESMIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; CELL DENSITY; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXTRACELLULAR MATRIX; FEMALE; FLUORESCENCE MICROSCOPY; GASTROCNEMIUS MUSCLE; HUMAN; HUMAN TISSUE; LIMB DEFECT; MALE; MIDDLE AGED; MITOCHONDRIAL RESPIRATION; MUSCLE FIBRIL; MUSCLE STRENGTH; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WALKING; AGED; CASE CONTROL STUDY; CELL COUNT; LEG; METABOLISM; MITOCHONDRION; PATHOLOGY; PATHOPHYSIOLOGY; SKELETAL MUSCLE;

AGED; CASE-CONTROL STUDIES; CELL COUNT; DESMIN; HUMANS; LOWER EXTREMITY; MIDDLE AGED; MITOCHONDRIA; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; PERIPHERAL ARTERIAL DISEASE; WALKING;

EID: 84925616262     PISSN: 00221554     EISSN: 15515044     Source Type: Journal    
DOI: 10.1369/0022155415569348     Document Type: Article

References (70)

1. Abraham SC,DeNofrio D,Loh E,Minda JM,Tomaszewski JE,Pietra GG,Reynolds C.Desmin myopathy involving cardiac, skeletal, and vascular smooth muscle: report of a case with immunoelectron microscopy.Hum Pathol. 1998;29:876-882
2. Anderson JD,Epstein FH,Meyer CH,Hagspiel KD,Wang H,Berr SS,Harthun NL,Weltman A,Dimaria JM,West AM,Kramer CM.Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism.J Am Coll Cardiol. 2009;54:628-635
3. Bloch RJ,Gonzalez-Serratos H.Lateral force transmission across costameres in skeletal muscle.Exerc Sport Sci Rev. 2003;31:73-78
4. Brass EP.Skeletal muscle metabolism as a target for drug therapy in peripheral arterial disease.Vasc Med. 1996;1:55-59
5. Brass EP,Hiatt WR.Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease.Vasc Med. 2000;5:55-59
6. Canton M,Neverova I,Menabo R,Van Eyk J,Di Lisa F.Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts.Am J Physiol Heart Circ Physiol. 2004;286:H870-877
7. Capetanaki Y.Desmin cytoskeleton: A potential regulator of muscle mitochondrial behavior and function.Trends in Cardiovascular Medicine. 2002;:339-348
8. Capetanaki Y,Bloch RJ,Kouloumenta A,Mavroidis M,Psarras S.Muscle intermediate filaments and their links to membranes and membranous organelles.Exp Cell Res. 2007;313:2063-2076
9. Capetanaki Y,Milner DJ,Weitzer G.Desmin in muscle formation and maintenance: knockouts and consequences.Cell Struct Funct. 1997;22:103-116
10. Carlsson L,Thornell LE.Desmin-related myopathies in mice and man.Acta Physiol Scand. 2001;171:341-348
11. Claeys KG,Fardeau M.Myofibrillar myopathies.Handb Clin Neurol. 2013;113:1337-1342
12. Clemen CS,Herrmann H,Strelkov SV,Schroder R.Desminopathies: pathology and mechanisms.Acta Neuropathol. 2013;125:47-75
13. Cluff K,Miserlis D,Naganathan GK,Pipinos,Koutakis P,Samal A,McComb RD,Subbiah J,Casale GP.Morphometric analysis of gastrocnemius muscle biopsies from patients with peripheral arterial disease: objective grading of muscle degeneration.Am J Physiol Regul Integr Comp Physiol. 2013;305:R291-299
14. Dalakas MC,Park KY,Semino-Mora C,Lee HS,Sivakumar K,Goldfarb LG.Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene.N Engl J Med. 2000;342:770-780
15. Diguet N,Mallat Y,Ladouce R,Clodic G,Prola A,Tritsch E,Blanc J,Larcher JC,Delcayre C,Samuel JL,Friguet B,Bolbach G,Li Z,Mericskay M.Muscle creatine kinase deficiency triggers both actin depolymerization and desmin disorganization by advanced glycation end products in dilated cardiomyopathy.J Biol Chem. 2011;286:35007-35019
16. Ervasti JM.Costameres: the Achilles’ heel of Herculean muscle.J Biol Chem. 2003;278:13591-13594
17. Evans NS,Liu K,Criqui MH,Ferrucci L,Guralnik JM,Tian L,Liao Y,McDermott MM.Associations of calf skeletal muscle characteristics and peripheral nerve function with self-perceived physical functioning and walking ability in persons with peripheral artery disease.Vasc Med. 2011;16:3-11
18. Gardner AW,Parker DE,Montgomery PS,Blevins SM,Teague AM,Casanegra AI.Monitored Daily Ambulatory Activity, Inflammation, and Oxidative Stress in Patients With Claudication.Angiology. 2013;65:491-496
19. Garg PK,Liu K,Ferrucci L,Guralnik JM,Criqui MH,Tian L,Sufit R,Nishida T,Tao H,Liao Y,McDermott MM.Lower extremity nerve function, calf skeletal muscle characteristics, and functional performance in peripheral arterial disease.J Am Geriatr Soc. 2011;59:1855-1863
20. Gaunt AS,Gans C.Architecture of chicken muscles: short-fibre patterns and their ontogeny.Proc R Soc Lond B Biol Sci. 1990;240:351-362
21. Goebel HH.Desmin-related neuromuscular disorders.Muscle Nerve. 1995;18:1306-1320
22. Goldfarb LG,Olive M,Vicart P,Goebel HH.Intermediate filament diseases: desminopathy. Adv Exp Med Biol. 2008;642:131-164
23. Goldfarb LG,Vicart P,Goebel HH,Dalakas MC.Desmin myopathy.Brain. 2004;127:723-734
24. Grounds MD,Sorokin L,White J.Strength at the extracellular matrix-muscle interface.Scand J Med Sci Sports. 2005;15:381-391
25. Grune T,Reinheckel T,Davies KJ.Degradation of oxidized proteins in mammalian cells.FASEB J. 1997;11:526-534
26. Hedberg B,Angquist KA,Henriksson-Larsen K,Sjostrom M.Fibre loss and distribution in skeletal muscle from patients with severe peripheral arterial insufficiency.Eur J Vasc Surg. 1989;3:315-322
27. Hedberg B,Angquist KA,Sjostrom M.Peripheral arterial insufficiency and the fine structure of the gastrocnemius muscle.Int Angiol. 1988a;7:50-59
28. Hedberg B,Langstrom M,Angquist KA,Fugl-Meyer AR.Isokinetic plantar flexor performance and fatiguability in peripheral arterial insufficiency. Effects of training vs. vascular surgery.Acta Chir Scand. 1988b;154:363-369
29. Huang D,Casale GP,Tian J,Lele SM,Pisarev VM,Simpson MA,Hemstreet GP.Udp-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancer.Int J Cancer. 2010;126:315-327
30. Huang D,Casale GP,Tian J,Wehbi NK,Abrahams NA,Kaleem Z,Smith LM,Johansson SL,Elkahwaji JE,Hemstreet GP.Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens.Cancer Epidemiol Biomarkers Prev. 2007;16:1371-1381
31. Janue A,Odena MA,Oliveira E,Olive M,Ferrer I.Desmin is oxidized and nitrated in affected muscles in myotilinopathies and desminopathies.J Neuropathol Exp Neurol. 2007a;66:711-723
32. Janue A,Olive M,Ferrer I.Oxidative stress in desminopathies and myotilinopathies: a link between oxidative damage and abnormal protein aggregation.Brain Pathol. 2007b;17:377-388
33. Kostrominova TY.Application of WGA lectin staining for visualization of the connective tissue in skeletal muscle, bone, and ligament/tendon studies.Microsc Res Tech. 2011;74:18-22
34. Koutakis P,Johanning JM,Haynatzki GR,Myers SA,Stergiou N,Longo GM,Pipinos.Abnormal joint powers before and after the onset of claudication symptoms.J Vasc Surg. 2010a;52:340-347
35. Koutakis P,Pipinos,Myers SA,Stergiou N,Lynch TG,Johanning JM.Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication.J Vasc Surg. 2010b;51:80-88
36. Koutakis P,Weiss DJ,Miserlis D,Shostrom VK,Papoutsi E,Ha DM,Carpenter LA,McComb RD,Casale GP,Pipinos.Oxidative damage in the gastrocnemius of patients with peripheral artery disease is myofiber type selective.Redox Biol. 2014;2:921-928
37. Lazarides E.Desmin and intermediate filaments in muscle cells.Results Probl Cell Differ. 1980;11:124-131
38. Li M,Dalakas MC.Abnormal desmin protein in myofibrillar myopathies caused by desmin gene mutations.Ann Neurol. 2001;49:532-536
39. Makitie J,Teravainen H.Histochemical changes in striated muscle in patients with intermittent claudication.Arch Pathol Lab Med. 1977;101:658-663
40. Makris KI,Nella AA,Zhu Z,Swanson SA,Casale GP,Gutti TL,Judge AR, II P.Mitochondriopathy of peripheral arterial disease.Vascular. 2007;15:336-343
41. Marbini A,Gemignani F,Scoditti U,Rustichelli P,Bragaglia MM,Govoni E.Abnormal muscle mitochondria in ischemic claudication.Acta Neurol Belg. 1986;86:304-310
42. McDermott MM,Criqui MH,Greenland P,Guralnik JM,Liu K,Pearce WH,Taylor L,Chan C,Celic L,Woolley C,O’Brien MP,Schneider JR.Leg strength in peripheral arterial disease: associations with disease severity and lower-extremity performance.J Vasc Surg. 2004;39:523-530
43. McDermott MM,Ferrucci L,Guralnik J,Tian L,Liu K,Hoff F,Liao Y,Criqui MH.Pathophysiological changes in calf muscle predict mobility loss at 2-year follow-up in men and women with peripheral arterial disease.Circulation. 2009;120:1048-1055
44. McDermott MM,Guralnik JM,Ferrucci L,Tian L,Pearce WH,Hoff F,Liu K,Liao Y,Criqui MH.Physical activity, walking exercise, and calf skeletal muscle characteristics in patients with peripheral arterial disease.J Vasc Surg. 2007;46:87-93
45. McDermott MM,Liu K,Tian L,Guralnik JM,Criqui MH,Liao Y,Ferrucci L.Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study.J Am Coll Cardiol. 2012;59:1159-1167
46. McDermott MM,Ohlmiller SM,Liu K,Guralnik JM,Martin GJ,Pearce WH,Greenland P.Gait alterations associated with walking impairment in people with peripheral arterial disease with and without intermittent claudication.J Am Geriatr Soc. 2001;49:747-754
47. Milner DJ,Mavroidis M,Weisleder N,Capetanaki Y.Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function.J Cell Biol. 2000;150:1283-1298
48. Monti RJ,Roy RR,Hodgson JA,Edgerton VR.Transmission of forces within mammalian skeletal muscles.J Biomech. 1999;32:371-380
49. Nakano S,Engel AG,Waclawik AJ,Emslie-Smith AM,Busis NA.Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron microscopy analysis of 10 cases.J Neuropathol Exp Neurol. 1996;55:549-562
50. Norgren L,Hiatt WR,Dormandy JA,Nehler MR,Harris KA,Fowkes FG,Group TIW.Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).J Vasc Surg. 2007;45:S5-67
51. Olive M,van Leeuwen FW,Janue A,Moreno D,Torrejon-Escribano B,Ferrer I.Expression of mutant ubiquitin (UBB+1) and p62 in myotilinopathies and desminopathies.Neuropathol Appl Neurobiol. 2008;34:76-87
52. Patel TJ,Lieber RL.Force transmission in skeletal muscle: from actomyosin to external tendons.Exerc Sport Sci Rev. 1997;25:321-363
53. Paulin D,Huet A,Khanamyrian L,Xue Z.Desminopathies in muscle disease.J Pathol. 2004;204:418-427
54. Pipinos,Judge AR,Selsby JT,Zhu Z,Swanson SA,Nella AA,Dodd SL.The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type.Vasc Endovascular Surg. 2008;42:101-112
55. Pipinos,Judge AR,Selsby JT,Zhu Z,Swanson SA,Nella AA,Dodd SL.The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction.Vasc Endovascular Surg. 2007;41:481-489
56. Pipinos,Judge AR,Zhu Z,Selsby JT,Swanson SA,Johanning JM,Baxter BT,Lynch TG,Dodd SL.Mitochondrial defects and oxidative damage in patients with peripheral arterial disease.Free Radic Biol Med. 2006;41:262-269
57. Pipinos,Sharov VG,Shepard AD,Anagnostopoulos PV,Katsamouris A,Todor A,Filis KA,Sabbah HN.Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease.J Vasc Surg. 2003;38:827-832
58. Pipinos,Shepard AD,Anagnostopoulos PV,Katsamouris A,Boska MD.Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle.J Vasc Surg. 2000;31:944-952
59. Regensteiner JG,Wolfel EE,Brass EP,Carry MR,Ringel SP,Hargarten ME,Stamm ER,Hiatt WR.Chronic changes in skeletal muscle histology and function in peripheral arterial disease.Circulation. 1993;87:413-421
60. Roger VL,Go AS,Lloyd-Jones DM,Benjamin EJ,Berry JD,Borden WB,Bravata DM,Dai S,Ford ES,Fox CS,Fullerton HJ,Gillespie C,Hailpern SM,Heit JA,Howard VJ,Kissela BM,Kittner SJ,Lackland DT,Lichtman JH,Lisabeth LD,Makuc DM,Marcus GM,Marelli A,Matchar DB,Moy CS,Mozaffarian D,Mussolino ME,Nichol G,Paynter NP,Soliman EZ,Sorlie PD,Sotoodehnia N,Turan TN,Virani SS,Wong ND,Woo D,Turner MB.Executive summary: heart disease and stroke statistics–2012 update: a report from the American Heart Association.Circulation. 2012;125:188-197
61. Sanger JW,Sanger JM,Franzini-Armstrong CMyology. Engel AGFranzini-Armstrong C, ed. New York, NY, USA: McGraw-Hill; 2004:45-65.
62. Schejter ED,Baylies MK.Born to run: creating the muscle fiber.Curr Opin Cell Biol. 2010;22:566-574
63. Segard BD,Delort F,Bailleux V,Simon S,Leccia E,Gausseres B,Briki F,Vicart P,Batonnet-Pichon S.N-acetyl-L-cysteine prevents stress-induced desmin aggregation in cellular models of desminopathy.PLoS One. 2013;8:e76361
64. Selcen D,Ohno K,Engel AG.Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients.Brain. 2004;127:439-451
65. Thompson JR,Swanson SA,Haynatzki G,Koutakis P,Johanning JM,Reppert PR,Papoutsi E,Miserlis D,Zhu Z,Casale GP,Pipinos.Protein Concentration and Mitochondrial Content in the Gastrocnemius Predicts Mortality Rates in Patients With Peripheral Arterial Disease.Ann Surg. 2014;:
66. Trotter JA.Structure-function considerations of muscle-tendon junctions.Comp Biochem Physiol A Mol Integr Physiol. 2002;133:1127-1133
67. Turrina A,Martinez-Gonzalez MA,Stecco C.The muscular force transmission system: role of the intramuscular connective tissue.J Bodyw Mov Ther. 2013;17:95-102
68. Weiss DJ,Casale GP,Koutakis P,Nella AA,Swanson SA,Zhu Z,Miserlis D,Johanning JM,Pipinos.Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease.J Transl Med. 2013;11:230
69. Winter DL,Paulin D,Mericskay M,Li Z.Posttranslational modifications of desmin and their implication in biological processes and pathologies.Histochem Cell Biol. 2014;141:1-16
70. Wurdeman SR,Koutakis P,Myers SA,Johanning JM,Pipinos,Stergiou N.Patients with peripheral arterial disease exhibit reduced joint powers compared to velocity-matched controls.Gait Posture. 2012;36:506-509